LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Piper Jaffray 20th Annual Health Care Conference on Wednesday, December 3 at 1:00 p.m. (ET) at the New York Palace Hotel.
